Blood test could catch hip disease before It's too late
NCT ID NCT07545616
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking for substances in the blood that can help doctors diagnose osteonecrosis of the femoral head (a condition where the hip bone dies) much earlier. Currently, many cases are missed or misdiagnosed. Researchers will collect blood from 300 people with suspected hip problems and use MRI scans to confirm the diagnosis, aiming to create a simple blood test for early detection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients with suspected osteonecrosis of the femoral head.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Aged between 18 and 70 years old (inclusive). 2. Patients with suspected ONFH. 3. Those who provide informed consent and volunteer to participate in this study. Exclusion Criteria: 1. Patients with a clear history of hip trauma. 2. Patients with ONFH secondary to traumatic factors such as femoral neck fracture and hip dislocation. 3. Patients complicated with severe mental illness or cognitive impairment who are unable to cooperate with questionnaire completion. 4. Patients who refuse to sign the informed consent form.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteonecrosis of the femoral head are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The First Affiliated Hospiatl of Henan Medical University
RECRUITINGXinxiang, Henan, 453003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Stem cells and oxygen therapy may save hips from collapse
- New drug RAB001 takes first step: safety check in healthy volunteers
- New combo treatment aims to save hips from collapse
- New drug aims to stop hip bone death from steroids
- Could your own bone marrow cells save your hip from collapse?
- New combo nerve block may ease hip surgery pain better